People

Eileen M. O'Reilly

Fiyinfolu Balogun, MD, PhD

Joshua Schoenfeld

Michael May, MD

Board-certified gastrointestinal medical oncologist at Memorial Sloan Kettering, specializing in pancreatic cancer and developing clinical trials for the next generation of GI cancer treatments.

Marc Hilmi

Senior Research Scholar studying tumor–immune interactions and mechanisms of immune suppression in cancer.

Vincenzo Nasca, MD

Medical oncologist and research fellow at sPARK Lab working on multi-omic characterization of pancreatic and biliary tract cancers, to identify molecular vulnerabilities and mechanisms of therapeutic resistance to innovative treatments.

Junmin Song, MD

Emma S. Kurz, MD, PhD

Physician-scientist and Hematology/Oncology Fellow at Memorial Sloan Kettering studying how exercise and IL-15 signaling shape antitumor immunity in pancreatic cancer.

Daeseong Kim, MD

First author of the lab’s inaugural biliary tract cancer study, identifying PI3K-pathway activation as a molecular determinant of chemotherapy benefit in advanced BTC (Clinical and Molecular Hepatology, 2026).

Catherine O'Connor

Takumi Sato

Mandi Kurtz